At a glance
- Originator Sankyo; Sanyo Kokusaku Pulp
- Developer Nonindustrial source; Sankyo; Sanyo Kokusaku Pulp
- Class Antidementias; Antiretrovirals; Neuroprotectants; Nucleosides; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 05 Jul 2001 Discontinued-Preclinical for HIV infections treatment in Japan (Unknown route)
- 05 Jul 2001 Discontinued-Preclinical for HIV infections treatment in USA (Unknown route)
- 21 Mar 1995 No-Development-Reported for HIV infections treatment in Japan (Unknown route)